Description
A dopamine D1 receptor antagonist; reduces dexbenzetimide- and scopolamine-induced locomotor stereotypy in rats at 0.005, 0.01, and 0.03 mg/kg; decreases ghrelin-induced increases in novel object exploration and food intake in rats at 100 µg/kg; reduces schedule-induced polydipsia in rats
Formal name: 8-bromo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepin-7-ol, monohydrobromide
Synonyms:
Molecular weight: 413.2
CAS: 108179-91-5
Purity: ≥98%
Formulation: A solid